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ABSTRACT  
SUZ12 is a core component of polycomb repressive complex 2 (PRC2) along with EZH2 
and EED. Recently, germline mutations in the SUZ12, EZH2 and EED genes have been 
reported in Weaver syndrome (WS) or Weaver-like syndrome, suggesting a functional link 
between PRC2 deficits and WS. However, only one case of a SUZ12 mutation presenting 
with Weaver-like syndrome has been reported. Here, we report a missense and a frameshift 
mutation in SUZ12 (c.1797A>C; p.Gln599His and c.844_845del; p.Ala282Glnfs*7), both 
of which are novel, in two individuals. Their clinical features included postnatal 
overgrowth, increased bifrontal diameter, large ears, round face, horizontal chin crease and 
skeletal anomalies, but did not fulfill the WS diagnostic criteria. These data provide strong 
evidence that SUZ12 mutations cause Weaver-like syndrome. 
 
Keywords: SUZ12, whole exome sequencing, Weaver syndrome, Weaver-like syndrome  
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Introduction 
Weaver syndrome (WS; MIM #277590) is a rare overgrowth disorder. In 2011, 
Khosravi et al. proposed clinical criteria to support the diagnosis of WS.1 Pathogenic 
variants in the genes encoding enhancer of zeste homolog 2 (EZH2) and embryonic 
ectoderm development (EED) have been identified in WS or Weaver-like syndrome.2-14 In 
particular, EZH2 was previously established as the causative gene for WS; thus, a 
molecular diagnostic approach is crucial for overgrowth patients.11 Nevertheless, 
individuals with an EZH2 mutation do not always exhibit the classical manifestations of 
WS.13 Recently, we reported a mutation in the gene encoding suppressor of zeste 12 
homolog (SUZ12) in an individual with Weaver-like syndrome.8 SUZ12 as well as EZH2 
and EED encode the subunits of the polycomb repressive complex 2 (PRC2).15 Here, we 
report two novel SUZ12 mutations in Brazilian and French families and describe their 
clinical phenotypes referring to the WS diagnostic criteria. 
 
Materials and Methods 
Two families (Figure 1A) affected with Weaver-like features were analyzed in this 
study. This study was approved by the Institutional Review Board of Yokohama City 
University School of Medicine and University of Sao Paulo School of Medicine. Peripheral 
blood samples and clinical information were collected after parental consent was provided. 
DNA was extracted from the peripheral blood leukocytes of families 1 and 2 using 
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QuickGene-610L (Fujifilm, Tokyo, Japan) and salt precipitation methods16, respectively. 
Whole exome sequencing (WES) was performed as previously described17 using DNA 
from the two affected probands and the unaffected parents in family 2. WES methods and 
candidate variant selection are described in the Supporting Information. 
 
Clinical reports 
The clinical information of the probands (individuals 1 and 2) is shown in Table 1, 
Figure 2 and Supporting Information.  
 
Identification of SUZ12 mutations 
After selecting the variants to investigate, missense (c.1797A>C, p.Gln599His) 
and frameshift (c.844_845del, p.Ala282Glnfs*7) variants in SUZ12 (NM_015355.2) were 
identified in individuals 1 and 2, respectively (Supplemental Figure S1 and Supplemental 
Tables S1 and S2). In individual 1, five missense variants were extracted as candidates 
(Supplemental Table S3). When we focused on highly pathogenic variants, only the SUZ12 
mutation remained (Supporting Information). Individual 1 harbored a heterozygous 
c.1797A>C variant in SUZ12, although this variant was absent in his father as determined 
by Sanger sequencing. Samples from his mother were unavailable for further testing 
because she had passed away. Therefore, we could not confirm the nature (either de novo or 
inherited) of the mutation in individual 1. The other four candidate variants were also 
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absent in his father as confirmed by Sanger sequencing; thus, their pathogenicity remains 
undetermined. The other c.844_845del variant occurred de novo in individual 2. In silico 
tools predicted that the p.Gln599His variant was deleterious: SIFT (score = 0); PolyPhen-2 
(score = 0.998); CADD (score = 26.6); PROVEAN (score = −2.8) and MutationTaster 
(score = Disease causing). The missense variant was located in the 
VRN2-EMF2-FIS2-SU(Z)12 (VEFS) domain in SUZ12 and the mutated glutamine is 
evolutionarily conserved from fish to humans (Figure 1B, C). Both variants were not 
registered in any control databases (Supporting Information). 
 
Discussion 
We found two novel SUZ12 mutations: p.Ala282Glnfs*7 and p.Gln599His in two 
unrelated individuals with Weaver-like syndrome. SUZ12 is an essential component of 
PRC2 together with EZH2 and EED. PRC2 has methyltransferase activity for lysine 27 on 
histone 3 (H3K27), which is catalyzed through the SET (Su(var)3-9, E(z) and Trithorax) 
domain of EZH2.18 H3K27 tri-methylation (H3K27me3) is an epigenetic-silence mark 
involved in the regulation of tissue- or developmental stage-specific gene expression.19 
Heterozygous knock-in mice carrying Ezh2 mutation (p.Val626Met) showed reduced 
H3K27me3 levels together with mild overgrowth.9 Also, heterozygous Ezh2 knockout mice 
showed advanced skeletal development.20 Whereas, interestingly, the Ezh2-null mice and 
the homozygous knock-in mice for p.Val626Met caused early lethality.9 These results 
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indicate that normal Ezh2 allele products and a partial loss-of-function (LoF) of PRC2 
might contribute to the overgrowth phenotype.9 In our previous report, a SUZ12 mutation 
(p.Glu610Val) in a patient with WS-like syndrome resulted in decreased levels of 
H3K27me3 in lymphoblastoid cells, consistent with a LoF of PRC2 activity.8 
SUZ12 has a high probability of Loss Intolerance (pLI) score of 1.0, indicating that 
LoF is likely to be involved. In gnomAD (http://gnomad.broadinstitute.org/), nine rare LoF 
variants were recorded in SUZ12. Of these, eight LoF variants were located in the last exon 
of SUZ12; thus, these variants might escape from nonsense-mediated mRNA decay (NMD) 
because they lack a downstream exon-junction complex that is a primary determinant of 
NMD.21 Proteins resulting from these variants retained a functional VEFS domain and 
might be functionally benign. These are also flagged as LoF variants with low confidence, 
suggesting somewhat dubious variant annotation or quality. The other variant 
(p.Lys246Valfs*7) in gnomAD, which was closely located to the variant detected in our 
proband, is predicted to disrupt the Zn-finger region and VEFS domain. These regions are 
required for PRC2 binding to a genomic target and stimulation of histone methyltransferase 
activity.22 The p.Lys246Valfs*7 and p.Ala282Glnfs*7 variants, located in SUZ12 exons 7 
and 8 respectively, may result in NMD because they are far upstream of the translational 
stop codon at the end of exon 16. Because the gnomAD data set includes individuals 
without severe pediatric diseases, an individual harboring the p.Lys246Valfs*7 variant 
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could have mild clinical presentation similar to our case, and might not have been excluded 
from recruitment to the various gnomAD populations. 
The missense mutation p.Gln599His was located near the p.Glu610Val mutation in 
the VEFS domain. The missense Z score from ExAC (http://exac.broadinstitute.org/) for 
SUZ12 was 3.68, indicating that SUZ12 has a lower number of missense variants than 
expected in the general population. Therefore, SUZ12 is considered an intolerant gene for 
missense variants, although the Z score itself may not directly support the pathogenicity of 
the variants. 
By the diagnostic criteria of Khosravi, 6 and 3 features were observed in 
individuals 1 and 2, respectively (Table I). The two patients and the previously reported 
patient (with p.Glu610Val) do not fulfill the criteria for WS. Patients with EED or EZH2 
mutations show classic WS phenotypes, and those with a SUZ12 mutation have common 
features including postnatal overgrowth, accelerated bone maturation, limb anomalies and 
umbilical hernia. Craniofacial features are present in patients with SUZ12, EED and EZH2 
mutations, but these appear differently; micrognathia/retrognathia is prominent in those 
with EED and EZH2 mutations but was not observed in our three patients with a SUZ12 
mutation. EZH2 and EED mutation-positive individuals generally exhibit specific facial 
phenotypes at birth or early childhood (< 1 year).2-8, 10, 11, 13, 14 In contrast, in the two 
SUZ12-mutated individuals (2 and 3), facial features were noted later at the age of 5 years 5 
months and 3 years, respectively. This gap might differentiate SUZ12-mutated patients 
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from those with EZH2 and EED mutations. Hoarse and low-pitched cry, hyper/hypotonia 
and excessive loose skin have not been recognized in patients with SUZ12 mutations. 
Individuals with SUZ12 mutations have varied levels of intellectual impairment as seen in 
those with EED and EZH2 mutations. Other phenotypes including multiple pigmented nevi, 
horizontal chin crease and scoliosis, and brain abnormalities are also present at various 
frequencies in patients with SUZ12, EED and EZH2 mutations. Therefore, pathogenic 
variants in SUZ12 likely cause a Weaver-like syndrome rather than WS, but further case 
reports are required. 
In conclusion, we found two novel SUZ12 mutations in two patients with 
Weaver-like syndrome. All three cases described to date have overlapping phenotypes and 
are from unrelated families of different ethnic backgrounds. Taken together, these data 
confirm that rare SUZ12 coding variants cause human overgrowth. Not all rare SUZ12 
coding variants are expected to cause overgrowth and other phenotypes may be associated 
with genetic variations in SUZ12.   
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Table 1. Clinical features in individuals with SUZ12 mutations 
Reference No. Present report 8 3, 4, 6, 8, 10, 12 2, 5, 7-9, 11, 13, 14 
Subjects Individual 1 Individual 2 Individual 3 Reported cases of EED 
mutation (7 patients) 
Reported cases of EZH2 
mutation (58 patients) 
Current age 19 y 9 y 4 m 11 y   
Sex Male Female Female   
Ethnicity Brazilian French Japanese   
SUZ12 mutation 
c.1797A>C, 
p.Gln599His 
c.844_845del, 
p.Ala282Glnfs*7 
c.1829A>T, 
p.Glu610Val 
  
Inheritance 
NA (not identified in 
father) 
De novo Inherited from 
mosaic father 
  
Diagnosis 
Weaver-like 
syndrome 
Weaver-like 
syndrome 
Weaver-like 
syndrome 
  
Development      
Gestation  Full term† 38 w 37 w 3 d   
Birth length 55.0 cm (+2.0 SD) 52.0 cm (+1.0 SD) 52.2 cm (+1.8 SD)   
Birth weight 4,500 g (+2.2 SD) 3,400 g (+0.5 SD) 3,552 g (+1.4 SD)   
Birth HC NA 33.5 cm (−0.5 SD) 34.6 cm (+1.2 SD)   
Current height 213.0 cm (+5.8 SD) 144.0 cm (+2.5 SD) 177.7 cm (+4.5 SD)   
Current weight 150.0 kg (+3.3 SD) 40.0 kg (+3.0 SD) 75.1 kg (+4.6 SD)   
Current HC 62.0 cm (+3.5 SD) 55.0 cm (+2.0 SD) 62.6 cm (+5.5 SD)   
Intellectual disability － － ＋ (moderate) 7/7; 100% (mild, 3; 
moderate, 3 patients; 
45/53; 85% (mild, 24; 
moderate, 12; severe, 3; 
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severe, 1 patient) unclassified, 6 patients) 
Physical phenotypes from WS criteria by Khosravi et al. (2011) ‡    
Excessive postnatal 
overgrowth 
＋ ＋ ＋ 5/5; 100% 51/55; 93% 
Macrocephaly ＋ － ＋ (plagiocephaly) 5/5; 100% 29/53; 55% 
Increased bifrontal diameter ＋ ＋ ＋ 3/4; 75% 6/7; 86% 
Hypertelorism ＋ － ＋ 4/5; 80% 10/11; 91% 
Prominent and/or long 
philtrum 
＋ (prominent) － － 3/5; 60% 6/8; 75% 
Micrognathia/retrognathia － － － 5/5; 100% 11/11; 100% 
Large ears ＋ ＋ ＋ 5/5; 100% 9/9; 100% 
Hoarse and low-pitched cry － － － 3/4; 75% 16/35; 46% 
Advanced general and carpal 
osseous maturation 
General; ＋ 
Carpal; － 
NA General; ＋ 
Carpal; ＋ 
5/5; 100% 34/34; 100% 
Broad metaphyses NA NA ＋ 3/4; 75% 2/4; 50% 
Other physical phenotypes      
Round face ＋ ＋ ＋ 5/5; 100% 3/3; 100% 
Flat occiput － NA ＋ 1/3; 33% 8/9; 89% 
Low nasal bridge － － － 2/4; 50% 1/1; 100% 
Limb anomalies Cubitus valgus, 
clinodactyly of 
bilateral 1st, 2nd and 
5th toes 
Short fifth fingers, 
clinodactyly and 
ungual hypoplasia of 
fifth toes 
Flexion disorder of 
fingers, 
camptodactyly 
(mild), ingrown 
nails of halluces, 
short 2nd and 4th 
toes (bilateral) 
4/5; 80% 9/9; 100% 
Horizontal chin crease ＋ ＋ － 3/4; 75% 1/1; 100% 
Skin pigmented nevi ＋ NA － 2/3; 67% 3/8; 38% 
Scoliosis － － Mild; <20° 3/4; 75% 10/51; 20% 
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Hypertonia － － － 4/5; 80% 17/48; 35% 
Hypotonia － － ＋ 3/5; 60% 23/49; 47% 
Excessive loose skin － NA － 1/4; 25% 23/43; 53% 
Umbilical hernia － ＋ ＋ 4/5; 80% 24/49; 49% 
Tumorigenesis － － － 0/3; 0% 4/52; 8% 
Other findings Downslanting 
palpebral fissures 
Hypertrichosis, 
hypermetropia, 
strabismus, 
non-febrile seizure, 
chronic constipation 
Abdominal 
distension at birth, 
plantar skin defects, 
knee joints 
contracture (mild), 
atrophy of 
gastrocnemius 
muscles 
  
Radiological examination      
Brain MRI Normal NA Enlarged lateral and 
third ventricles, 
arachnoid cysts, 
Chiari malformation 
type I 
2/5; 40% (Substantial 
white matter volume 
loss, thin corpus 
callosum and 
ventriculomegaly) 
5/7; 71% 
(Ventriculomegaly, 
delayed myelination, 
cerebellar hypoplasia, 
polymicrogyria and 
Chiari malformation) 
† Precise gestational week of conception was unrecorded for Individual 1. ‡ Khosravi et al. proposed that WS patients should have at 
least 8 of 10 features. 
SUZ12 mutations are based on NM_015355.2. Abbreviations: NA, not assessed; HC, head circumference; SD, standard deviation; 
MRI, magnetic resonance imaging; m, month(s); y, year(s); w, week(s); d, day(s); +, present; –, not present. (See Supplementary 
Table S4).  
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FIGURE LEGENDS 
Figure 1. Familial pedigrees and SUZ12 mutations. (A) Familial pedigrees. (B) Human SUZ12 
(NP_ 056170) protein structure and mutations. Novel mutations are shown in bold. p.Glu610Val 
was previously reported. WDB, WD-40 binding domain; Zn, Zn-finger region; VEFS, 
VRN2-EMF2-FIS2-SU(Z)12 domain. (C) Evolutionary conservation of p.Gln599 and p.Glu610 
in SUZ12 from flies to humans.  
 
Figure 2. Clinical features of the affected individuals. Individual 1 at the age of 8 months (A), 1 
year (B), 2 years (C) and 15 years (D, E): round face, broad forehead, large ears, hypertelorism 
and large feet were significantly noted in childhood (A-C). In adulthood (D, E), individual 1 had 
a horizontal chin crease, deep philtrum and multiple pigmented nevi. (F) Hand is relatively large 
with no nail hypoplasia. (G) Mild clinodactyly of the 1st, 2nd and 5th toes are shown (white 
arrow head). Individual 2 at 5 years and 5 months (H, I): short fifth fingers with mild 
clinodactyly (white arrow heads) and hypoplastic nail on the fifth toe (black arrow head) are 
shown. 
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